First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape

Treatment paradigm for metastatic clear cell renal cell carcinoma (mccRCC) has changed dramatically over the recent decades. From cytokines, interleukin-2 and interferon-α to tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors, during the last decade, combinations of immune check...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Shuchi, Labaki, Chris, Karachaliou, Georgia Sofia, Choueiri, Toni K, Zhang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895741/
https://www.ncbi.nlm.nih.gov/pubmed/35641205
http://dx.doi.org/10.1093/oncolo/oyab056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895741/
https://www.ncbi.nlm.nih.gov/pubmed/35641205
http://dx.doi.org/10.1093/oncolo/oyab056

Ejemplares similares